Designing Facilities

DSP

Why More Product Upstream Creates New Pressure Downstream

Pharma's Almanac

Enzymatic Synthesis

Transforming Enzymatic Processes into Commercial-Scale Manufacturing

Kohei Mori

Kaneka

Pathfinder

Platform Development vs. Molecule-Specific Process Development: Which Strategy Is Better for Biologics?

Nice Insight

Oncolytic Viruses

Manufacturing Oncolytic Viruses: Where Complexity Demands Experience

Mathias Kahl

IDT Biologika

CCS and CMC

Packaging Returns to the Center of CMC Strategy

Pharma's Almanac

iPSCs

For iPSC Therapies, Manufacturing Consistency May Mean Preserving Function

Pharma's Almanac

Pathfinder

Enzymatic Synthesis vs. Fermentation for Biomanufacturing: Which Production Strategy Is Better?

Nice Insight

Single-Use

The Changing Economics of Single-Use Biomanufacturing

Pharma's Almanac

Biologics Platform

Platform-Based Drug Substance Development: Applying Prior Knowledge Across Modalities

Mathias Kahl

IDT Biologika

Pathfinder

Conventional Peptide Synthesis vs. Recombinant Peptide Production: Which Manufacturing Strategy Is Better?

Nice Insight

Productivity

The Next Productivity Leap in Mammalian Cell Culture

Pharma's Almanac